Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2021-02-04 12:18 Tx date 2021-02-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Williams, Mark Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+235,322 vol |
457,415 | |
Filed 2021-02-04 12:17 Tx date 2021-02-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Williams, Mark Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-330,000 vol |
340,000 | |
Filed 2020-12-18 19:43 Tx date 2020-09-29 |
$AGN
Algernon Pharmaceuticals Inc. |
Williams, Mark Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+222,093 vol |
222,093 | |
Filed 2020-12-18 19:42 Tx date 2020-09-29 |
$AGN
Algernon Pharmaceuticals Inc. |
Williams, Mark Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-330,000 vol |
670,000 | |
Filed 2020-08-27 13:34 Tx date 2020-08-21 |
$AGN
Algernon Pharmaceuticals Inc. |
Williams, Mark Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+1,000,000 vol |
1,000,000 | |
Filed 2020-08-27 13:33 Tx date 2018-10-22 |
$AGN
Algernon Pharmaceuticals Inc. |
Williams, Mark Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSUs
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-06-23 20:27 Tx date 2020-04-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Williams, Mark Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,250,000 vol |
1,750,000 | |
Filed 2020-06-23 20:26 Tx date 2020-02-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Williams, Mark Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
500,000 | |
Filed 2020-06-23 20:24 Tx date 2018-10-22 |
$AGN
Algernon Pharmaceuticals Inc. |
Williams, Mark Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-06-23 20:24 Tx date 2018-10-22 |
$AGN
Algernon Pharmaceuticals Inc. |
Williams, Mark Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-12-09 Tx date 2015-12-01 |
$DMA
DiaMedica Inc. |
Williams, Mark Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,000
+240,000 vol $0.15 each |
1,152,500 |